Galenica AG
Galenica AG (GALNF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
galnf · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Galenica AG (GALNF) measures how much investors pay for each dollar of the company's trailing earnings. GALNF's current PE ratio of 23.11x is calculated by dividing its stock price of $115.00 by its TTM earnings per share of $3.63. +11.1% elevated vs 5Y avg 20.8x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2013 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 12 fiscal years · Front-end computedMinQ1 · 25%25.4x
MedianQ3 · 75%47.9x
Max
At 23.11x, GALNF's current P/E is within its average historical range over the past 12 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Distribution · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Galenica AGYou GALNF | $5.7B | 23.11x | — | $3.63 |
 Mediclinic International plc ANHGY | $4.0B | N/A | — | — |
 Alfresa Holdings Corporation ARHCF | $2.2B | 8.15x | — | $231.09 |
 Ascentage Pharma Group International ASPHF | $1.7B | N/A | — | -$3.40 |
 McKesson Europe AG CAKFY | $5.4B | N/A | — | -$0.05 |
 Indivior PLC INVVY | $3.0B | N/A | — | -$0.38 |
 Indivior PLC IZQVF | $2.9B | N/A | — | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 25.35x | $3.63 | +36.2% | |
2024-12-31 FY2024 | 18.61x | $3.67 | +2.4% | |
2023-12-31 FY2023 | 18.17x | $3.48 | -13.3% | |
2022-12-31 FY2022 | 20.94x | $3.32 | -0.1% | |
2021-12-31 FY2021 | 20.97x | $3.38 | +6.1% | |
2020-12-31 FY2020 | 19.77x | $3.48 | -33.3% | |
2019-12-31 FY2019 | 29.66x | $2.54 | +16.4% | |
2018-12-31 FY2018 | 25.48x | $3.00 | -18.4% | |
2017-12-31 FY2017 | 31.23x | $2.43 | -34.2% | |
2016-12-31 FY2016 | 47.47x | $1.67 | -1.0% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Galenica AG (GALNF) measures how much investors pay for each dollar of the company's trailing earnings. GALNF's current PE ratio of 23.11x is calculated by dividing its stock price of $115.00 by its TTM earnings per share of $3.63.
Frequently asked questions
GALNF pe ratio · 6 questionsGALNF's current PE ratio is 23.11x as of 2026-06-08, based on a stock price of $115.00 and TTM EPS of $3.63. Data sourced from Financial Modeling Prep via GALNF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Galenica AG SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08